Search

Your search keyword '"Bootsma H."' showing total 997 results

Search Constraints

Start Over You searched for: Author "Bootsma H." Remove constraint Author: "Bootsma H."
997 results on '"Bootsma H."'

Search Results

2. OP0113 GENOME-WIDE ASSOCIATION STUDY OF Ro/SSA+ AND Ro/SSA-SJÖGREN’S CASES IN THE SJÖGREN’S GENETIC NETWORK (SGENE) DEMONSTRATES DIVERGENT GENETIC ARCHITECTURE IN PATIENT SUBPHENOTYPES

3. OP0040 DOSE DEPENDENT MODULATION OF PROTEOMIC SIGNATURES BY IANALUMAB IN PATIENTS WITH SJÖGREN’S DISEASE

4. OP0008 SAFETY AND EFFICACY OF ISCALIMAB IN PATIENTS WITH SJÖGREN’S DISEASE: 48-WEEK RESULTS FROM A RANDOMISED, PLACEBO-CONTROLLED, PHASE 2B DOSE-RANGING TRIAL

5. POS0391 THE MSQUASH AS MEASUREMENT TOOL FOR DAILY PHYSICAL ACTIVITY: TRANSLATION AND CROSS-CULTURAL ADAPTATION INTO ENGLISH, FIELD-TESTING IN DIFFERENT RHEUMATIC DISEASES AND CLINICAL VALIDATION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS

6. POS1247 CHARACTERIZATION OF 284 PATIENTS PRESENTING WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT AT DIAGNOSIS OF SJÖGREN DISEASE: RESULTS FROM THE SJÖGREN BIG DATA REGISTRY

7. Efficacité et sécurité de l’iscalimab (un AcM anti-CD40) chez les patients atteints de maladie de Sjögren : résultats à 48 semaines d’un essai de phase 2b, randomisé et contrôlé par placebo (TWINSS)

9. Modulation dose-dépendante des signatures protéomiques par le ianalumab chez les patients atteints de la maladie de Sjögren

13. Reumatische klachten als uiting van algemene ziekten

15. Need for harmonized long-term multi-lake monitoring of African Great Lakes

16. At the cutting-edge: what's the latest in imaging to diagnose Sjögren's disease?

17. AB0520 TREATMENT OF PRIMARY SJÖGREN’S SYNDROME BY INHIBITING FCRN: A PHASE 2 RANDOMIZED, PLACEBO CONTROLLED, DOUBLE-BLIND, PROOF OF CONCEPT STUDY WITH EFGARTIGIMOD

19. POS1454 ARE ULTRASOUND SALIVARY PARENCHYMAL ABNORMALITIES MORE SEVERE IN PRIMARY SJÖGREN PATIENTS WITH A HIGHER DISEASE DURATION? A TRANSVERSAL INTERNATIONAL STUDY

22. POS1456 DIAGNOSTIC ACCURACY OF THE LABIAL SALIVARY GLAND BIOPSY INCREASES WHEN OTHER HISTOPATHOLOGICAL PARAMETERS BESIDES FOCUS SCORE ARE TAKEN INTO ACCOUNT IN PRIMARY SJÖGREN’S SYNDROME

28. Performance du nouveau critère de réponse du syndrome de Sjögren primitif (SSp), le STAR (Sjögren's tool for assessing response) : réanalyse de 9 essais cliniques dans le SSp

34. Childhood-onset of primary Sjögren’s syndrome: phenotypic characterization at diagnosis of 158 children

37. Labial and parotid salivary gland histopathology in primary Sjögren’s syndrome

40. Digital image analysis of intraepithelial B-lymphocytes as an objective alternative to assess lymphoepithelial lesions in salivary glands of Sjögren's syndrome patients

46. Addressing the clinical unmet needs in primary Sjögren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts

47. 2021 DORIS definition of remission in SLE: Final recommendations from an international task force.

48. Subsurface Organic Matter Emission Registration System (SOMERS) : Beschrijving SOMERS 1.0, onderliggende modellen en veenweidenrekenregels

49. Need for harmonized long-term multi-lake monitoring of African Great Lakes

50. LWKM zware metalen : Emissieberekeningen voor de EmissieRegistratie 1990-2019

Catalog

Books, media, physical & digital resources